Paul Oldham
Analyst · Cowen & Company
Thank you, Steve, and good morning, everyone. In the second quarter, we delivered revenue slightly above the midpoint of our guidance, despite a challenging operating environment. Total revenue of $361 million was up 6% year-over-year and 3% sequentially. We also generated record revenues in our Plasma Power products and in our service business. Customer demand remained very healthy again during the quarter, resulting in an order book which provides solid demand visibility into 2022. On the other hand, new COVID-related restrictions in Malaysia resulted in our factory idling for several days and further limited our capacity output for semiconductor products in June. In addition, shortages of critical parts continued to be a challenge across all our markets, limiting revenue upside, cost pressures associated with the supply chain were worse than expected, resulting in Q2 gross margins below our target. Favorable discrete items in our tax rate largely offset these shortfalls this quarter, resulting in earnings of $1.25 per share. We expect the operating environment to remain challenging, particularly in the near-term. Supply chain and pandemic-related restrictions continue to be very dynamic with a few key suppliers and ongoing COVID risk in Malaysia being the most significant issues. While we have made some improvements, recent decommits and extended lead times are expected to have a meaningful impact on our Q3 outlook before improving in the fourth quarter. With respect to Malaysia, we are actively to get our employees vaccinated and plan to leave additional production capacity in Shenzhen through the end of the year to mitigate the impact and enable a quick recovery. More broadly, we are working closely with both our suppliers and customers to optimize deliveries, while maintaining capacity across our factory network to be able to respond quickly as supply improves. While these challenges will have a significant impact on our results in the near-term, we remain confident in our ability to meet our medium and long-term strategic goals as the operating environment normalizes. Now, let me discuss our Q2 results. Overall, demand continued to strengthen across our markets, which contributed to the greater than $125 million increase in our order book. Revenues were impacted to a varying degree by market based on parts availability. Semiconductor sales were $177 million, up 21% from last year and just off the record set in Q1. Demand further strengthened throughout the quarter and our team overcame some of the COVID-related restrictions in Malaysia, resulting in record sales of our Plasma Power products. Without the impact of these restrictions late in the quarter, our semi sales would have increased sequentially. Revenue from our industrial medical markets grew 6% sequentially, and 17% from a year ago to $83 million. Our order book in I&M is particularly strong, giving us visibility to support revenue growth well into 2022. Datacenter computing revenue was $69 million, up 17% sequentially with growth coming from both enterprise and hyperscale applications. Telecom and networking revenue was $32 million in the quarter, which was lower than expected due solely to material constraints. Non-GAAP gross margin for the quarter was 38%. The sequential decline was primarily due to less favorable mix and higher than expected logistics and supply chain costs. We also saw lower factory productivity exacerbated by the Malaysia restrictions. While we expect gross margins to come under additional pressure in the second half, we continue to be confident in our ability to meet our long-term gross margin goal of over 40% as the supply chain environment and related constraints improve. Non-GAAP operating expenses were $82.6 million, up about $3 million from last quarter and slightly above our expectations. The sequential change was due to planned increases in annual labor costs, the addition of Tegam and higher customer and program spending. Operating margins for the quarter were 15.1%. Other expense was $1.9 million, including $1.1 million of interest expense and $48,000 of FX losses. We continue to expect other expense to be in the $1.5 million to $2 million range going forward. Our non-GAAP tax rate – our non-GAAP tax expense was $4.7 million or 8.9%, primarily on favorable discrete items, which will not repeat next quarter. Looking forward, we continue to expect the GAAP and non-GAAP tax rate to remain in the 15% range. Earnings for the quarter were $1.25 per share, up from $1.18 a year ago, but down from last quarter. Turning now to the balance sheet. We ended the second quarter with total cash of $510 million and a net cash of $196 million, up slightly from Q1. Operating cash flow was $34 million or just under 10% of revenue. During the quarter, we invested $15 million in the acquisition of Tegam and paid $5.4 million in CapEx, $4.4 million towards our debt and $3.9 million in dividend payments. In addition, during the quarter, we repurchased $6.5 million worth of stock at $90.34 a share. From a working capital perspective, our days of networking capital were about flat at ninety six days. However, inventory increased by $40 million, as we continued to acquire raw materials to support higher demand levels. Churns were 3.3 times. Although it may take a few quarters, we expect churns to rebound as critical parts shortages to abate and we are able to fully ship demand. Accounts payable rose to $207 million, with the associated DPO of 82 days, largely offsetting the increased level of inventory in the short-term. Receivables rose slightly to $243 million and DSO was unchanged to 61 days. Finally, today, we announced that our Board of Directors increased our stock repurchase authorization to $200 million in support of our long-term, opportunistic share repurchase strategy. Now, let me turn to guidance. Overall demand continues to be strong and our order book supports growth well into 2022. However, a more challenging supply chain environment, particularly around a few integrated circuit suppliers, and uncertainties related to COVID restrictions, are expected to have a larger impact to our revenue levels in the near-term. As a result, we expect Q3 revenues to be approximately $340 million, plus or minus $15 million. However, based on current parts projections, we expect revenues to rebound and grow modestly year-over-year in the fourth quarter with second half revenues approximately flat to first half levels. We expect Q3 gross margin to be around 35% to 36% on lower volumes and higher supply chain costs, with the full impact of material and logistics costs being realized in the fourth quarter, before improving early next year. Operating expenses should be about flat on slightly higher R&D and the full quarter of Tegam, as we continued to invest in critical programs. As a result, we expect Q3 non-GAAP earnings per share to be $0.80 plus or $0.20. Looking forward, we are encouraged about the increasing in customer demand for our proprietary power solutions, strong order book and the solid traction we are achieving in our strategic programs. We are taking multiple actions to mitigate the impact of supply chain and operating challenges, while staying focused on delivering new products and next-generation technologies to our customers. As the current operating environment improves, we believe the strong demand, coupled with actions we are taking will enable us to deliver solid revenue and earnings growth in 2022. With that, let's take your questions. Operator?